Metabolic Syndrome. Metabolic disorder, unspecified
Conditions
Interventions
Intervention 1: Intervention group: Satureja hortensis dry leaf 450 mg in a capsule per day for 70 days. Intervention 2: Control group: Starch and green edible color 450 mg in a capsule per day for 70
Treatment - Drugs
Placebo
Intervention group: Satureja hortensis dry leaf 450 mg in a capsule per day for 70 days
Control group: Starch and green edible color 450 mg in a capsule per day for 70 days
Sponsors
Shiraz University of Medical Sciences, Vice Chancellor for Research Affairs
Eligibility
Sex/Gender
All
Age
30 Years to No maximum
Inclusion criteria
Inclusion criteria: Inclusion criteria: Waist circumference men = 102cm or 40in and women = 88cm or 35in, Fasting blood glucose = 110 mg/dl, HDL-cholesterol for men < 40 mg/dl and for women < 50 mg/dl, Triglycerides = 150 mg/dl, Blood pressure = 130/85 mm Hg. Exclusion criteria: hypothyroidism; alcoholism; smoking; auto immune disease; chronic pancreatitis; liver dysfunction; kidney disorder or nephritic syndrome; simultaneous subscription in other interventional study; any inflammatory disease or incidence of infection at start or during the study period; consumption of other drug such as aspirin, propranolol, NSAIDs, any form of steroids and any kind of blood glucose and lipid lowering agent; angioplasty or heart attack positive history; pregnancy and lactating.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fasting Blood Glucose. Timepoint: Begining of study first day and at the end of study 70th day. Method of measurement: Laboratory kit, Pars Azmoon.;LDL-cholesterol. Timepoint: Begining of study first day and at the end of study 70th day. Method of measurement: Laboratory kit, Pars Azmoon.;High sensetive- C Reactive Protein. Timepoint: Begining of study first day and at the end of study 70th day. Method of measurement: Laboratory kit, Pars Azmoon.;Blood Pressure (systolic and diastolic). Timepoint: Begining of study first day and at the end of study 70th day. Method of measurement: Beurer Upper Arm Digital Blood Pressure Monitor.;HDL-cholesterol. Timepoint: Begining of study first day and at the end of study 70th day. Method of measurement: Laboratory kit, Pars Azmoon.;Triglyceride. Timepoint: Begining of study first day and at the end of study 70th dayBegining and end of study. Method of measurement: Laboratory kit, Pars Azmoon. | — |
Secondary
| Measure | Time frame |
|---|---|
| Alanine Aminotransferase. Timepoint: Begining of study first day and at the end of study 70th day. Method of measurement: Laboratory kit, Pars Azmoon.;Aspartate Aminotransferase. Timepoint: Begining of study first day and at the end of study 70th day. Method of measurement: Laboratory kit, Pars Azmoon.;Complete Blood Count. Timepoint: Begining of study first day and at the end of study 70th day. Method of measurement: CBC counter machine, Sysmex. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFarzad Nikaein
School of Nutrition, Shiraz University of Medical Sciences
Outcome results
None listed